Navigation Links
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for Second Quarter 2013
Date:8/8/2013

br>(0.89)Weighted average number of basic and diluted common shares14,673,77114,554,50214,667,24412,394,869Consolidated Balance Sheets(In thousands) June 30,  December 31, 20132012 (unaudited) Assets:  Cash, cash equivalents, short term investments and restricted cash$
57,306$
75,697  Interest receivable300327  Amounts receivable6,439714  Prepaid expenses and other current assets3,5423,755  Property, equipment and other assets1,7211,523Total assets$
9,308$
82,016Liabilities and stockholders' equity:  Accounts payable and accrued liabilities$
,540$
7,050  Current portion of long-term obligations1,0891,084  Warrant liability1,0873,422  Long term liabilities3,9074,253  Stockholders' equity52,68566,207Total liabilities and stockholders' equity$
9,308$
82,016 

 

 

Conference Call Details OncoGenex will host a conference call at 4:30 p.m. Eastern Time today, Thursday, August 8, 2013, to provide a business update and discuss the second quarter 2013 results.

A live event will be available on the Investor Relations section of the OncoGenex website at www.OncoGenex.com. Alternatively, you may access the live conference call by dialing 877-606-1416 (U.S. & Canada) or 707-287-9313 (International). A replay of the webcast will be available approximately two hours after the call and will be archived for 90 days.

ABOUT ONCOGENEX
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. (NYSE:  TEVA)
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. OncoGenex Announces Multiple Trials in Progress Presentations at the 2013 ASCO Annual Meeting
2. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
3. OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
4. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
5. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
6. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
7. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity Growth Conference
8. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
9. Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, CA. The presentation is scheduled to begin at 11 a.m. ET / 8 a.m. PT
10. OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.
11. Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014 The Brandeis Medical Center, led by Dr. ... a premier and affordable laser tattoo removal experience with the advanced ... is in providing high quality cosmetic services with cutting edge medical ... " Southern California has seen a dramatic increase ...
(Date:1/14/2014)... Emergency Critical Care, a LifeCentre partner practice, located at 165 Fort ... first in Loudoun County to receive a ... M. Barnes , Medical Director, is a well-seasoned veterinarian of more ... , are avid scuba divers. "As altitude skiers and hikers, we ...
(Date:1/14/2014)... Oligomerix, Inc. , a privately held company pioneering the ... and related neurodegenerative disorders, announced today the relocation of ... as of January 15, 2014 and expanded lease ... College. Oligomerix, which is focused on the ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... ROCHESTER, N.Y., Feb. 2, 2011 VirtualScopics, Inc. (Nasdaq: ... clinical trials, announced today that Mr. Jeff Markin, the company,s ... overview at the upcoming 13th Annual BIO CEO & Investor ... Markin,s presentation will be on Monday, February 14, 2011 at ...
... 2, 2011 Sonoma Orthopedic Products announced that ... agreement with Ai-Medic, a subsidiary of Olympus® Business ... orthopedic products in the Japanese market, especially in ... includes significant license fee and revenue commitments. ...
Cached Medicine Technology:VirtualScopics to Present at the 13th Annual BIO CEO & Investor Conference 2
(Date:7/9/2014)... Researchers at the Perelman School of Medicine at the ... Cancer Institute have received an $8 million grant from ... of photodynamic light therapy (PDT) in patients with malignant ... most often manifests itself in the lining of the ... asbestos. The grant will fund a clinical trial and ...
(Date:7/9/2014)... into the metabolism of stromal support cells and immune ... these cell types in the development of diseases ... and cancer. That was the conclusion of a review ... the leading journal Nature . , Prof. Peter ... call. The metabolism of cancer cells has been examined ...
(Date:7/9/2014)... N.Y. Although feelings are personal and subjective, ... code that objectively represents emotions across different senses, ... by Cornell University neuroscientist Adam Anderson. , "We ... the orbitofrontal cortex, an area of the brain ... code which captures an individual,s subjective feeling," says ...
(Date:7/9/2014)... World Cup highlights, Brian Williams refreshing old school rap ... on railings. A University of Colorado Cancer Center study ... that YouTube also allows researchers, journals, and health advocates ... skin cancer and prevention. , "No matter what field ... we communicate around the world," says Chante Karimkhani, MD ...
(Date:7/9/2014)... print and poor printing on prescription labels handed ... lead to errors in taking medication, according to ... CNIB (Canadian National Institute for the Blind)., The ... Journal , found that labels on prescription medications ... recommended guidelines for legibility. , By simply following ...
Breaking Medicine News(10 mins):Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Wake-up call for more research into cell metabolism 2Health News:Study cracks how the brain processes emotions 2Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... and tolerable exercise can be given to children's with ... a better heart function//. The study was conducted in ... Rhodes. ,The study was conducted in 16 ... with severe congenital heart disease and were given a ...
... proposed by a study by Florian Koppelstatter, University Hospital Innsbruck ... with 100 mg caffeine can boost short-term memory.// ,The ... aged 26 to 47. Participants were tested when they consumed ... 100 mg caffeine can be found in two cups of ...
... presented by Austrian researchers at the annual meeting of ... Friday say that caffeine has the ability to boost ... brain that control this activity. ,Caffeine is ... drinks and chocolate. The researchers tested 15 subjects who ...
... born with a hearing in both ears in India, but she ... year as result of a successful cochlear implant when she was ... was three months old. But they did not lose heart and ... she behaves like any other normal child. ,"Sonam is one ...
... 6 December 2005, along with his wife Melinda. Chennai and ... he reviews the progress of his $200 million HIV/AIDS initiative ... list of Microsoft. Gates' fourth visit in two years will ... key government officials in addition to business leaders, academicians, industry ...
... The Singapore Health Ministry said that they will be raising ... Balaji Sadasivan, Minister of State for Health has asked the ... thousands of women and children infected with HIV. It is ... singapore are married and reports say that there could be ...
Cached Medicine News:Health News:Early Intervention Required For The Hearing Impaired 2Health News:Bill Gates Takes Personal Interest in AIDS Program 2
Used in stat or routine procedures utilizing the dip or rack method of staining blood smears or as a counter-stain in reticulocyte counting. Comes as a part of a kit (8 oz each), or in 16 oz, 32 oz a...
Our Reticulocyte Stain is a specialized hematology stain for identifying immature erythrocytes. These immature erythrocytes stain blue in a fine mesh network within the erythrocyte. Mature erythrocyt...
... Wright-Giemsa Stain is a single ... fixative, buffer, and stain for ... blood smears. It is packaged ... ease of use and is ...
This Wright-Giemsa is a dual-use stain for peripheral blood and bone marrow smears. It produces somewhat darker results when compared with Giemsa, particularly in the blue to magenta shades....
Medicine Products: